19th Call for proposals 2019 - Innovative Medicines Initiative 2 Joint Undertaking - Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities H2020-JTI-IMI2-2019-19-single-stage Closed!


The scope of the restricted Call will be to support further research activities in those exceptional cases where it is necessary to enable successful consortia to build on the achievements of their initial action, move onto the next step of the challenge, and maximise the impacts of the initial action results.


Funded actions are expected to significantly:

  • enhance the impacts already delivered by the consortium in the initial action;
  • improve the drug development process;
  • have public health benefits and improve European citizens’ health and well-being;
  • contribute to the EU’s industrial leadership including small and medium-sized enterprises (SMEs);
  • have an impact on regulatory, health technology assessment, and healthcare practices, if relevant;
  • further maximise the IMI2 JU public-private partnership value by harnessing support from different stakeholders, including the mobilisation of funds through the inclusion of contributing partners

European community funding

The Community provisional funding available for the call for proposals is:

  • 20,00 Million EUR (Global Budget)

All the important deadlines

  • 26 September 2019 - 2 years ago (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Call for proposals (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes